Name (Synonyms) | Correlation | |
---|---|---|
drug1727 | PCL COV05 - COVID 19 Ag Rapid FIA test (Rapid Antigen Test) Wiki | 1.00 |
Name (Synonyms) | Correlation |
---|
There is one clinical trial.
This research is planned to illustrate the efficacy of Therapeutic Plasma Exchange (TPE) treatment in COVID-19 patients with resistant cytokine storm state.
Description: Number of patients deaths of the total of patients included
Measure: mortality Time: 28 dayDescription: to calculate the mean time with oxygen therapy
Measure: the mean time with oxygen therapy Time: through study completion, and average of 1 monthDescription: to calculate the mean time with Non-invasive mechanical ventilation
Measure: the mean time with Non-invasive mechanical ventilation Time: through study completion, and average of 1 monthDescription: to calculate the mean time of intubation
Measure: the mean time of intubation Time: through study completion, and average of 1 monthDescription: To calculate the mean of PaO2/FiO2
Measure: respiratory function parameters Time: through study completion, and average of 1 monthDescription: To calculate the mean of levels of oxygen saturation
Measure: respiratory function parameters Time: through study completion, and average of 1 monthDescription: to evaluate the lung extension of pneumonia
Measure: radiological lung extension Time: through study completion, and average of 1 monthDescription: Days of hospitalization in survivors and/or days at ICU throughout the study
Measure: mean duration of hospitalization and ICU use Time: through study completion, and average of 1 monthDescription: Percentage of patients with dialysis
Measure: the requirement of additional organ support Time: through study completion, and average of 1 monthDescription: To evaluate the effect of TPE on the serum levels of inflammatory markers
Measure: the levels of IL-6 Time: through study completion, and average of 1 monthDescription: To calculate the number of adverse events in patients with COVID-19 treated with TPE
Measure: Incidence of adverse events Time: through study completion, and average of 1 monthDescription: To evaluate the time to RT-PCR virus negativity
Measure: time to reverse-transcriptase polymerase chain reaction (RT-PCR) virus negativity Time: through study completion, and average of 1 monthDescription: To evaluate the effect of TPE on the serum levels of inflammatory markers
Measure: the levels of CRP Time: through study completion, and average of 1 monthDescription: To evaluate the effect of TPE on the serum levels of inflammatory markers
Measure: the levels of procalcitonin (PCT) Time: through study completion, and average of 1 monthDescription: To evaluate the effect of TPE on the serum levels of inflammatory markers
Measure: levels of D-dimer Time: through study completion, and average of 1 monthDescription: To evaluate the effect of TPE on the serum levels of inflammatory markers
Measure: levels of ferritin Time: through study completion, and average of 1 month